课题基金 / 基金详情

MEDICAL THERAPY OF BENIGN PROSTATIC HYPERTROPHY

MEDICAL THERAPY OF BENIGN PROSTATIC HYPERTROPHY
良性前列腺肥大的药物治疗
批准号：
6115734
负责人：
HERBERT LEPOR
金额：
$2.1万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6115734
关键词：
antihypertensive agents benign prostate hyperplasia biomarker clinical research clinical trials drug screening /evaluation finasteride human subject human therapy evaluation pathologic process ultrasonography

项目摘要

项目成果

HERBERT LEPOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The primary objective is to ascertain if medical therapy with finasteride and or doxazocin delays or prevents the progression of BPH. Secondary objectives will include assessment of the natural history of BPH, maximal uroflow, symptom scores and medical outcomes. A subgroup of patients will undergo ultrasound, prostate biopsy, and serum hormonal determination in order to determine the histopathology of BPH and test existing biomarkers for their prognostic ability regarding response to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UROLOGICAL RESEARCH TRAINING GRANT
UROLOGICAL RESEARCH TRAINING GRANT
UROLOGICAL RESEARCH TRAINING GRANT
UROLOGICAL RESEARCH TRAINING GRANT
海外基金